Uric Acid as a Mediator of Diabetic Nephropathy
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2011/09/01
-
Journal
-
Indian UGC (journal)
-
Refrences93
-
Citations65
-
Diana I. Jalal
-
David M. Maahs
-
Peter Hovind
-
Takahiko Nakagawa
Cite
Jalal, Diana I., et al. “Uric Acid As a Mediator of Diabetic Nephropathy”. Seminars in Nephrology, vol. 31, no. 5, 2011, pp. 459-65, https://doi.org/10.1016/j.semnephrol.2011.08.011.
Jalal, D. I., Maahs, D. M., Hovind, P., & Nakagawa, T. (2011). Uric Acid as a Mediator of Diabetic Nephropathy. Seminars in Nephrology, 31(5), 459-465. https://doi.org/10.1016/j.semnephrol.2011.08.011
Jalal DI, Maahs DM, Hovind P, Nakagawa T. Uric Acid as a Mediator of Diabetic Nephropathy. Seminars in Nephrology. 2011;31(5):459-65.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the genitourinary system
Urology
Medicine
Medicine (General)
You May Also Like
- Proinflammatory actions of angiotensins
- Cell biology and molecular mechanisms of injury in ischemic acute renal failure
- Prediction equations to estimate glomerular filtration rate: an update
- The Banff 97 working classification of renal allograft pathology
- Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| The role of hyperuricemia and gout in kidney and cardiovascular disease | Cleveland Clinic Journal of Medicine |
| 2008 | |
| Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004 | American Journal of Kidney Diseases |
| 104 | 2008 |
| CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004 | American Journal of Kidney Diseases |
| 124 | 2008 |
| Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the angiotensin ii antagonist losartan trial | Hypertension |
| 2011 | |
| Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease | 2011 |
Refrences Analysis
The category
Medicine: Medicine (General) 48
is the most frequently represented among the references in this article. It primarily includes studies from Diabetes The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Large-scale cross-ancestry genome-wide meta-analysis of serum urate | Nature Communications |
| 2024 | |
| Expression of pro-inflammatory cytokines (IL-6 & IL-18) exacerbate the risk of diabetic nephropathy in the Pakistani population | Molecular Biology Reports |
| 2 | 2023 |
| Genetic susceptibility to diabetic kidney disease is linked to promoter variants of XOR | Nature Metabolism |
| 5 | 2023 |
| Serum uric acid is associated with chronic kidney disease in elderly Chinese patients with diabetes | Renal Failure |
| 2023 | |
Redox regulation in diabetic kidney disease | American Journal of Physiology-Renal Physiology |
| 1 | 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 34
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Nlrp3 Inflammasome Activation in Type 2 Diabetes: Is It Clinically Relevant? and was published in 2012. The most recent citation comes from a 2024 study titled Large-scale cross-ancestry genome-wide meta-analysis of serum urate. This article reached its peak citation in 2020, with 11 citations. It has been cited in 57 different journals, 40% of which are open access. Among related journals, the International Journal of Molecular Sciences cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.